Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ponte Vedra, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Cadrenal Therapeutics, Inc. has filed 269 SEC EDGAR filings since 15 Jul 2022

SEC filing history

Showing 226-250 of 269 matching filings.

Per page
25
Current page
10
4

4 filing

Filing date
22 Mar 2023
Reporting date
21 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Mar 2023
Reporting date
16 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2023
Reporting date
10 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
25 Jan 2023
Reporting date
19 Jan 2023
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2023
Reporting date
24 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2023
Reporting date
24 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2023
Reporting date
24 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-269372

REGISTRATION STATEMENT

Filing date
24 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-267562

PROSPECTUS

Filing date
23 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-267562

PROSPECTUS

Filing date
23 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
20 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-41596

CERT filing

Filing date
20 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-267562

EFFECT filing

Filing date
19 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-41596

REGISTRATION OF CERTAIN CLASSES OF SECURITIES

Filing date
17 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-267562

REGISTRATION STATEMENT

Filing date
17 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-267562

REGISTRATION STATEMENT

Filing date
28 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .